Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yassmine Akkari

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of the Association of Genetic Technologists|September 4, 2004
Fanconi Anemia: A Decade of DiscoveriesYassmine Akkari, Susan Olson
Genes|August 28, 2025
Optical Genome Mapping: A New Tool for Cytogenomic AnalysisBrynn Levy, Rachel D Burnside, Yassmine Akkari
Cold Spring Harbor Molecular Case Studies|June 5, 2019
Implementation of cancer next-generation sequencing testing in a community hospitalYassmine Akkari, Tamara Smith, Jennifer Westfall, et al.
Cancer Genetics|July 8, 2022
A novel heptasomy 21 associated with complete loss of heterozygosity and loss of function RUNX1 mutation in acute myeloid leukemiaFei Yang, Yassmine Akkari, Guang Fan, et al.
Genetics in Medicine Open|December 13, 2024
Exploring current challenges in the technologist workforce of clinical genomics laboratoriesYassmine Akkari, Sheila Dobin, Robert G Best, et al.
DNA Repair|September 12, 2003
siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cellsDonald Bruun, Alexandra Folias, Yassmine Akkari, et al.
Human Molecular Genetics|September 2, 2005
Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joiningScott Houghtaling, Amy Newell, Yassmine Akkari, et al.
Leukemia|November 12, 2021
Recommendations for future extensions to the HGNC gene fusion nomenclatureAlex H Wagner, Yassmine Akkari, Marilyn Li, et al.
Leukemia|December 15, 2021
Correction to: Recommendations for future extensions to the HGNC gene fusion nomenclatureAlex H Wagner, Yassmine Akkari, Marilyn Li, et al.
Cancer Research|January 25, 2005
Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout miceScott Houghtaling, Laura Granville, Yassmine Akkari, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of the Association of Genetic Technologists|September 4, 2004
Fanconi Anemia: A Decade of DiscoveriesYassmine Akkari, Susan Olson
Genes|August 28, 2025
Optical Genome Mapping: A New Tool for Cytogenomic AnalysisBrynn Levy, Rachel D Burnside, Yassmine Akkari
Cold Spring Harbor Molecular Case Studies|June 5, 2019
Implementation of cancer next-generation sequencing testing in a community hospitalYassmine Akkari, Tamara Smith, Jennifer Westfall, et al.
Cancer Genetics|July 8, 2022
A novel heptasomy 21 associated with complete loss of heterozygosity and loss of function RUNX1 mutation in acute myeloid leukemiaFei Yang, Yassmine Akkari, Guang Fan, et al.
Genetics in Medicine Open|December 13, 2024
Exploring current challenges in the technologist workforce of clinical genomics laboratoriesYassmine Akkari, Sheila Dobin, Robert G Best, et al.
DNA Repair|September 12, 2003
siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cellsDonald Bruun, Alexandra Folias, Yassmine Akkari, et al.
Human Molecular Genetics|September 2, 2005
Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joiningScott Houghtaling, Amy Newell, Yassmine Akkari, et al.
Leukemia|November 12, 2021
Recommendations for future extensions to the HGNC gene fusion nomenclatureAlex H Wagner, Yassmine Akkari, Marilyn Li, et al.
Leukemia|December 15, 2021
Correction to: Recommendations for future extensions to the HGNC gene fusion nomenclatureAlex H Wagner, Yassmine Akkari, Marilyn Li, et al.
Cancer Research|January 25, 2005
Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout miceScott Houghtaling, Laura Granville, Yassmine Akkari, et al.
Pageof 4